Current Report Filing (8-k)
May 25 2017 - 6:11AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of Earliest Event Reported):
April 17, 2017
PetLife
Pharmaceuticals, Inc.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-52445
|
|
33-1133537
|
(State
or other jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
of
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
38
West Main St., Hancock, MD
|
|
21750
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (844) 473-8543
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item
1.01 Entry into a Material Definitive Agreement.
On
May 10, 2017, Dr. Geoff’s by PetLife, Inc. (“Dr. Geoff’s by PetLife”), a subsidiary of PetLife Pharmaceuticals,
Inc. (“PetLife,” or the “Company”), entered into an asset purchase agreement and a supply agreement with
Healthy Life Pets, LLC (“Healthy Life Pets”) to acquire certain assets, including the intellectual property of Healthy
Life Pets’ product line, including the trademarked brand, “Dr. Geoff’s Real Pet Food,” and to purchase
product for a period of time from Healthy Life Pets. The purchase price of the assets was 1,450,000 shares of common stock of
the Company, 450,000 of which were issued at execution, with the remaining 1,000,000 shares of common stock vesting over two years.
The supply agreement, when fulfilled, will require the issuance of 50,000 shares of common stock of the Company to Healthy Life
Pets. All shares of Company common stock to be issued pursuant to these agreements are subject to restrictions on resale pursuant
to a leak out agreement.
Dr.
Geoff’s by PetLife projects a national rollout of the product line in the latter part of 2017. Also, Dr. Geoff’s by
PetLife projects the inclusion of VitalZul™, the Company’s patent pending, non-toxic, bioactive formulation, into
a second-generation line of pet food.
The
foregoing descriptions of the asset purchase agreement, supply agreement, and leak out agreement are qualified in their entirety
by the full text of the agreements, which are filed as Exhibits 10.1, 10.2 and 10.3 to, and incorporated by reference in, this
report.
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.
On
April 17, 2017, as announced in a press release on the following day, Geoffrey Broderick resigned as President of the Company
to focus on the Company’s pet food division, Dr. Geoff’s by PetLife, and the projected rollout of the Dr. Geoff’s
product line through direct response marketing to consumers through infomercials and Internet promotions. Mr. Broderick has an
extensive background in this industry; therefore, this move to the subsidiary is strategic to meet the Company’s goals.
Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On
April 19, 2017, the Company organized in the State of Maryland a wholly-owned subsidiary, Dr. Geoff’s by PetLife, to operate
the Company’s pet food division.
Item
9.01 Financial Statements and Exhibits.
The
exhibits listed in the following Exhibit Index are filed as part of this report:
Exhibit
No.
|
|
Description
|
|
|
|
10.1
|
|
Asset
Purchase Agreement between Healthy Life Pets, LLC and Dr. Geoff’s by PetLife, Inc.
|
10.2
|
|
Supply
Agreement between Healthy Life Pets, LLC and Dr. Geoff’s by PetLife, Inc.
|
10.3
|
|
Leak
Out Agreement between Healthy Life Pets, LLC, Dr. Geoff’s by PetLife, Inc., and PetLife Pharmaceuticals, Inc.
|
99.1
|
|
Press
Release on April 18, 2017, “PetLife Finalizes Negotiations for Dr. Geoff’s Real Food for Pets”
|
99.2
|
|
Press
Release on May 23, 2017, “PetLife Closes Acquisition of Assets for Dr. Geoff’s Real Food for Pets”
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
PETLIFE PHARMACEUTICALS, INC.
|
(Registrant)
|
|
|
|
Dated:
May 25, 2017
|
By:
|
/s/
Ralph T. Salvagno, MD
|
|
|
Ralph
T. Salvagno, MD
|
|
|
Chief
Executive Officer
|
Petlife Pharmaceuticals (CE) (USOTC:PTLF)
Historical Stock Chart
From May 2024 to Jun 2024
Petlife Pharmaceuticals (CE) (USOTC:PTLF)
Historical Stock Chart
From Jun 2023 to Jun 2024